R&D expense · Fiscal year 2025
| 1 | AstraZenecaAZN | $14.2B |
|---|---|---|
| 2 | GSKGSK | $9.9B |
| 3 | Arm HoldingsARM | $2.8B |
| 4 | ShellSHEL | $1.2B |
| 5 | CNH IndustrialCNH | $1.0B |
| 6 | UnileverUL | $945M |
| 7 | Rio TintoRIO | $524M |
| 8 | British American Tobacco P.L.CBTI | $472M |
| 9 | HaleonHLN | $417M |
| 10 | Smith & NephewSNN | $296M |